Tonix Pharmaceuticals Holding Corp.’s TNXP share price has surged by 18.09%, which has investors questioning if this is right ...

PWS causes those affected to constantly feel hungry and never satisfied, even after consuming large amounts of food.

New treatments for Prader-Willi Syndrome and hemophilia; FDA fast tracks a chlamydia vaccine candidate; over-the-counter test cleared for identifying chlamydia, gonorrhea and trichomoniasis.

Tonix Pharmaceuticals Holding Corp.’s TNXP share price has dipped by 10.58%, which has investors questioning if this is right ...

The United States Food and Drug Administration (US FDA) has approved VYKAT™ XR, a significant milestone as the first approved treatment for hyperphagia in Prader-Willi syndrome (PWS).

A new drug could change everything for children like seven-year-old daughter, Liliana, who has Prader-Willi syndrome, a rare ...

The FDA has approved Vykat XR (diazoxide choline) for the treatment of hyperphagia in adults and pediatric patients 4 years ...

Piper Sandler主办的电话会议中，一位精神病学关键意见领袖 (KOL)表示，VYKAT XR的获批已引起国际关注。根据 InvestingPro 数据，这种热情促使SLNO在过去一周内实现了42.76%的显著涨幅。PWS倡导组织已广泛传播这一信息，导致大量患者和照护者咨询如何获取该治疗方案。

Over the last 7 days, the United States market has dropped 3.4%, yet it remains up by 6.1% over the past year, with earnings anticipated to grow by 14% annually in the coming years. In this context, ...

近日，Soleno Therapeutics 宣布，美国 FDA 已批准 VYKAT XR（二氮嗪胆碱，Diazoxide choline）缓释片上市，用于治疗患有普拉德-威利综合征（PWS）的成人和 4 ...